PMID- 18160224 OWN - NLM STAT- MEDLINE DCOM- 20080415 LR - 20181113 IS - 0306-4522 (Print) IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 151 IP - 2 DP - 2008 Jan 24 TI - Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells. PG - 622-9 AB - Tumor necrosis factor-alpha (TNF-alpha), a ubiquitous pro-inflammatory cytokine, is an important mediator in the immune-neuroendocrine system that affects the CNS. The present study demonstrates that treatment with TNF-alpha activates microglia to increase TNF-alpha production in primary cultures of glial cells isolated from wild-type (WT) mice and mice deficient in the inducible form of nitric oxide synthase (iNOSKO). However, mitochondrial dysfunction in WT neurons occurs at lower concentrations of TNF-alpha when neurons are directly treated with TNF-alpha or co-cultured with TNF-alpha-treated microglia than iNOSKO neurons similarly treated. Immunofluorescent staining of primary neurons co-cultured with TNF-alpha-treated microglia reveals that the antioxidant enzyme in mitochondria, manganese superoxide dismutase (MnSOD), is co-localized with nitrotyrosine in WT but not in iNOSKO primary neuronal cells. Importantly, the percentage of surviving neurons is significantly reduced in WT neurons compared with iNOSKO neurons under identical treatment conditions. Together, the results suggest that TNF-alpha activates microglia to produce high levels of TNF-alpha and that production of nitric oxide (NO) in neurons is an important factor affecting MnSOD nitration and subsequent mitochondrial dysfunction. FAU - Tangpong, J AU - Tangpong J AD - School of Allied Health Sciences and Public Health, Walailak University, Nakhon Si Thammarat, 80160, Thailand. njibjoy@yahoo.com FAU - Sompol, P AU - Sompol P FAU - Vore, M AU - Vore M FAU - St Clair, W AU - St Clair W FAU - Butterfield, D A AU - Butterfield DA FAU - St Clair, D K AU - St Clair DK LA - eng GR - CA94853/CA/NCI NIH HHS/United States GR - CA-80152/CA/NCI NIH HHS/United States GR - P01 AG005119/AG/NIA NIH HHS/United States GR - AG-05119/AG/NIA NIH HHS/United States GR - R01 CA094853/CA/NCI NIH HHS/United States GR - P01 AG005119-21/AG/NIA NIH HHS/United States GR - R01 CA080152/CA/NCI NIH HHS/United States GR - R01 CA094853-05/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20071113 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Nitrates) RN - 0 (Tetrazolium Salts) RN - 0 (Thiazoles) RN - 0 (Tumor Necrosis Factor-alpha) RN - 31C4KY9ESH (Nitric Oxide) RN - 3604-79-3 (3-nitrotyrosine) RN - 42HK56048U (Tyrosine) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type II) RN - EC 1.15.1.1 (Superoxide Dismutase) RN - EUY85H477I (thiazolyl blue) SB - IM MH - Animals MH - Cell Death/genetics/physiology MH - Cell Survival/drug effects MH - Cells, Cultured MH - Coculture Techniques MH - Immunohistochemistry MH - Mice MH - Mice, Knockout MH - Mitochondria/*physiology MH - Neuroglia/*physiology MH - Neurons/*metabolism MH - Nitrates/*metabolism MH - Nitric Oxide/*biosynthesis MH - Nitric Oxide Synthase Type II/biosynthesis/genetics MH - Superoxide Dismutase/*metabolism MH - Tetrazolium Salts MH - Thiazoles MH - Tumor Necrosis Factor-alpha/*physiology MH - Tyrosine/analogs & derivatives/metabolism PMC - PMC3437053 MID - NIHMS39189 EDAT- 2007/12/28 09:00 MHDA- 2008/04/16 09:00 PMCR- 2012/09/08 CRDT- 2007/12/28 09:00 PHST- 2007/07/12 00:00 [received] PHST- 2007/10/17 00:00 [revised] PHST- 2007/10/31 00:00 [accepted] PHST- 2007/12/28 09:00 [pubmed] PHST- 2008/04/16 09:00 [medline] PHST- 2007/12/28 09:00 [entrez] PHST- 2012/09/08 00:00 [pmc-release] AID - S0306-4522(07)01336-X [pii] AID - 10.1016/j.neuroscience.2007.10.046 [doi] PST - ppublish SO - Neuroscience. 2008 Jan 24;151(2):622-9. doi: 10.1016/j.neuroscience.2007.10.046. Epub 2007 Nov 13.